CAMBRIDGE, Mass.--(BUSINESS WIRE)--Curis, Inc. (NASDAQ: CRIS), a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that the Company will be presenting at Merriman Curhan Ford’s Investor Summit at 9:00 a.m. EST on November 10, 2009, in New York City.
